Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination.
Abdulrahman Z, de Miranda N, van Esch EMG, de Vos van Steenwijk PJ, Nijman HW, J P Welters M, van Poelgeest MIE, van der Burg SH. Abdulrahman Z, et al. Among authors: de vos van steenwijk pj, van poelgeest mie, de miranda n, van der burg sh, van esch emg. J Immunother Cancer. 2020 Mar;8(1):e000563. doi: 10.1136/jitc-2020-000563. J Immunother Cancer. 2020. PMID: 32169871 Free PMC article.
A pre-existing coordinated inflammatory microenvironment is associated with complete response of vulvar high-grade squamous intraepithelial lesions to different forms of immunotherapy.
Abdulrahman Z, de Miranda NFCC, Hellebrekers BWJ, de Vos van Steenwijk PJ, van Esch EMG, van der Burg SH, van Poelgeest MIE. Abdulrahman Z, et al. Among authors: de miranda nfcc, de vos van steenwijk pj, van poelgeest mie, van der burg sh, van esch emg. Int J Cancer. 2020 Nov 15;147(10):2914-2923. doi: 10.1002/ijc.33168. Epub 2020 Jul 3. Int J Cancer. 2020. PMID: 32574376 Free PMC article.
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions.
Abdulrahman Z, Hendriks N, J Kruse A, Somarakis A, J M van de Sande A, J van Beekhuizen H, M J Piek J, de Miranda NFCC, Kooreman LFS, F M Slangen B, van der Burg SH, de Vos van Steenwijk PJ, van Esch EMG. Abdulrahman Z, et al. Among authors: de vos van steenwijk pj. J Immunother Cancer. 2022 Nov;10(11):e005288. doi: 10.1136/jitc-2022-005288. J Immunother Cancer. 2022. PMID: 36323430 Free PMC article.
The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis.
van de Sande AJM, Kengsakul M, Koeneman MM, Jozwiak M, Gerestein CG, Kruse AJ, van Esch EMG, de Vos van Steenwijk PJ, Muntinga CLP, Bramer WM, van Doorn HC, van Kemenade FJ, van Beekhuizen HJ. van de Sande AJM, et al. Among authors: de vos van steenwijk pj. Int J Gynaecol Obstet. 2024 Jan;164(1):66-74. doi: 10.1002/ijgo.14953. Epub 2023 Jun 23. Int J Gynaecol Obstet. 2024. PMID: 37350560 Review.
Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
Schuurman TN, Schaafsma M, To KH, Verhoef VMJ, Sikorska K, Siebers AG, Wenzel HHB, Bleeker MCG, Roes EM, Zweemer RP, de Vos van Steenwijk PJ, Yigit R, Beltman JJ, Zusterzeel PLM, Lok CAR, Bekkers RLM, Mom CH, van Trommel NE. Schuurman TN, et al. Among authors: de vos van steenwijk pj. Lancet Oncol. 2023 Dec;24(12):1349-1358. doi: 10.1016/S1470-2045(23)00467-9. Epub 2023 Nov 9. Lancet Oncol. 2023. PMID: 37952541
Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC-2): A randomised controlled trial.
van de Sande AJM, van Baars R, Koeneman MM, Gerestein CG, Kruse AJ, van Esch EMG, de Vos van Steenwijk PJ, Muntinga CLP, Willemsen SP, van Doorn HC, van Kemenade FJ, van Beekhuizen HJ. van de Sande AJM, et al. Among authors: de vos van steenwijk pj. BJOG. 2024 Mar 31. doi: 10.1111/1471-0528.17808. Online ahead of print. BJOG. 2024. PMID: 38556619
Surgery followed by persistence of high-grade squamous intraepithelial lesions is associated with the induction of a dysfunctional HPV16-specific T-cell response.
de Vos van Steenwijk PJ, Piersma SJ, Welters MJ, van der Hulst JM, Fleuren G, Hellebrekers BW, Kenter GG, van der Burg SH. de Vos van Steenwijk PJ, et al. Among authors: van der hulst jm, van der burg sh. Clin Cancer Res. 2008 Nov 15;14(22):7188-95. doi: 10.1158/1078-0432.CCR-08-0994. Clin Cancer Res. 2008. PMID: 19010835
25 results